Lymphocyte pharmacodynamics are not associated with autoimmunity or efficacy after alemtuzumab.

Wiendl H, Carraro M, Comi G, Izquierdo G, Kim HJ, Sharrack B, Tornatore C, Daizadeh N, Chung L, Jacobs AK, Hogan RJ, Wychowski LV, Wijmeersch BV